CCIA
ITOS

Campbell & Co Investment Adviser’s iTeos Therapeutics ITOS Stock Holding History

Campbell & Co Investment Adviser’s Portfolio ITOS Stock Details ITOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-72,262
Closed -$720K – 1242
2025
Q2 		$720K Buy
+72,262
New +$582K 0.05% 648

Other funds holding ITOS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Campbell & Co Investment Adviser's ITOS Position: Q3 2025 in Review

Campbell & Co Investment Adviser sold out of iTeos Therapeutics (ITOS) in Q3 2025, closing a stake of 72,262 shares — an estimated $720K sold.

Campbell & Co Investment Adviser first reported a position in ITOS in Q2 2025 and held it in 1 quarter. The position peaked at $720K in Q2 2025. 1 fund tracked by Wall St. Rank holds ITOS as of Q3 2025.

  • Campbell & Co Investment Adviser reported no remaining iTeos Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 72,262 iTeos Therapeutics shares in Q3 2025, an estimated $720K.
  • Campbell & Co Investment Adviser first reported a position in iTeos Therapeutics in Q2 2025 and held it in 1 quarter.
  • Campbell & Co Investment Adviser's iTeos Therapeutics position peaked at $720K in Q2 2025.
  • 1 fund tracked by Wall St. Rank held iTeos Therapeutics as of Q3 2025.

Based on Campbell & Co Investment Adviser's 13F filing for Q3 2025, filed 28 Oct 2025.